SLC5A2 and hydrops fetalis: Experimental and clinical research has shown that SGLT2 inhibitors affect exercise tolerance through a wide range of effects on cardiac myocytes, skeletal muscle, and on adipose tissue which could potentially counteract the mechanisms by which HF causes exercise intolerance (4).